Affinage

GK2

Glycerol kinase 2 · UniProt Q14410

Length
553 aa
Mass
60.6 kDa
Annotated
2026-04-28
12 papers in source corpus 2 papers cited in narrative 2 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GK2 encodes a 458-amino-acid protein with sequence homology to galactokinases (EC 2.7.1.6) that can complement galactokinase-deficient yeast, demonstrating intrinsic galactokinase catalytic capacity (PMID:1438294). However, when expressed in mammalian COS cells, GK2 exhibits negligible galactokinase activity compared to GALK1, indicating it is not the primary galactokinase for galactose metabolism in mammalian cells, and its physiological function remains uncharacterized (PMID:7542884).

Mechanistic history

Synthesis pass · year-by-year structured walk · 2 steps
  1. 1992 High

    Identification of GK2 as a human galactokinase-encoding gene resolved whether a second galactokinase locus existed in the human genome, establishing that GK2 possesses intrinsic galactokinase activity.

    Evidence Functional complementation of gal1- S. cerevisiae by human GK2 cDNA expression

    PMID:1438294

    Open questions at the time
    • Activity was demonstrated only in yeast; mammalian cell activity was untested
    • Endogenous tissue expression pattern of GK2 was not determined
    • No comparison with GALK1 activity level was performed
  2. 1995 Medium

    Demonstrating that GK2 has negligible galactokinase activity in mammalian cells established that it is not the primary galactokinase and raised the question of whether it has an alternative physiological substrate or function.

    Evidence Heterologous expression in COS cells with galactokinase activity assay and Northern blot comparison to GALK1

    PMID:7542884

    Open questions at the time
    • Single-lab observation not independently replicated in additional mammalian systems
    • No alternative substrates or binding partners were tested
    • Endogenous protein expression and tissue distribution remain uncharacterized

Open questions

Synthesis pass · forward-looking unresolved questions
  • The physiological role of GK2 in mammalian cells remains unknown — whether it acts on an alternative sugar substrate, functions in a specific tissue context, or has a non-catalytic role has not been addressed experimentally.
  • No substrate specificity profiling beyond galactose has been performed
  • No loss-of-function studies in mammalian models exist
  • No structural or interactome data are available

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0016740 transferase activity 1
Pathway
R-HSA-1430728 Metabolism 1

Evidence

Reading pass · 2 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1992 GK2 encodes a human galactokinase (EC 2.7.1.6) of 458 amino acids, located on chromosome 15, with 29% identity to yeast galactokinase; its galactokinase activity was demonstrated by functional complementation of a galactokinase-deficient (gal1-) Saccharomyces cerevisiae strain. Functional complementation in yeast (gal1- strain rescue by human cDNA expression) Proceedings of the National Academy of Sciences of the United States of America High 1438294
1995 GK2 cDNA expressed in COS cells produced only very low (or undetectable) galactokinase activity compared to GALK1, suggesting GK2 is not the primary enzyme for galactose metabolism in mammalian cells. Heterologous expression in COS cells with galactokinase activity assay and Northern blot Biochemical and biophysical research communications Medium 7542884

Source papers

Stage 0 corpus · 12 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1992 Cloning of a human galactokinase gene (GK2) on chromosome 15 by complementation in yeast. Proceedings of the National Academy of Sciences of the United States of America 27 1438294
2013 Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer's Disease. Acta naturae 17 24303204
2015 Identification of a panel of complex autoantigens (LGALS3, PHB2, MUC1, and GK2) in combination with CA15-3 for the diagnosis of early-stage breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 16 26289852
2014 Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro. The International journal of neuroscience 12 24950445
2019 A Novel Dipeptide NGF Mimetic GK-2 Selectively Activating the PI3K/AKT Signaling Pathway Promotes the Survival of Pancreatic β-Cells in a Rat Model of Diabetes. Acta naturae 5 31024748
1995 Comparison of the enzymatic activities of human galactokinase GALK1 and a related human galactokinase protein GK2. Biochemical and biophysical research communications 5 7542884
2015 Effectiveness of GK-2, a Nerve Growth Factor Mimetic, in Preventing Post-Resuscitation Changes in the Brain. Bulletin of experimental biology and medicine 4 26388581
2025 Pharmacokinetics, tissue distribution, in vivo metabolism and liver microsomal metabolism of GK-A, GK-2 and Eucomic acid in rats were studied by liquid chromatography-tandem mass spectrometry and mass spectrometry imaging of Ginkgo semen extract. Journal of ethnopharmacology 1 41207346
2023 Protective effect of GK2 fused BLVRA protein against oxidative stress-induced dopaminergic neuronal cell damage. The FEBS journal 1 36688733
2022 Low molecular weight NGF mimetic GK-2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats. Clinical and experimental pharmacology & physiology 1 35748804
2010 [Neuroprotective effect of low-molecular peptide mimetic (GK-2) of nerve growth factor is related to activated synthesis of heat shock proteins (hsp32 and hsp70) and increased phosphorylation of TrkA receptor]. Eksperimental'naia i klinicheskaia farmakologiia 1 21395008
2015 [Effect of the nerve growth factor mimetic GK-2 on post-resuscitation expression of neurotrophic factors]. Patologicheskaia fiziologiia i eksperimental'naia terapiia 0 26571801